ProShare Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112K Sell
19,449
-216
-1% -$1.25K ﹤0.01% 1857
2025
Q1
$130K Sell
19,665
-4,438
-18% -$29.3K ﹤0.01% 1783
2024
Q4
$210K Buy
24,103
+5,873
+32% +$51.2K ﹤0.01% 1862
2024
Q3
$356K Buy
18,230
+4,075
+29% +$79.6K ﹤0.01% 1348
2024
Q2
$291K Sell
14,155
-3,859
-21% -$79.5K ﹤0.01% 1306
2024
Q1
$384K Buy
18,014
+1,588
+10% +$33.9K ﹤0.01% 1257
2023
Q4
$236K Buy
16,426
+2,407
+17% +$34.6K ﹤0.01% 1547
2023
Q3
$128K Buy
14,019
+1,114
+9% +$10.2K ﹤0.01% 1586
2023
Q2
$137K Buy
12,905
+510
+4% +$5.4K ﹤0.01% 1633
2023
Q1
$152K Sell
12,395
-1,614
-12% -$19.7K ﹤0.01% 1514
2022
Q4
$174K Buy
14,009
+1,388
+11% +$17.2K ﹤0.01% 1527
2022
Q3
$173K Buy
12,621
+303
+2% +$4.15K ﹤0.01% 1439
2022
Q2
$226K Sell
12,318
-6,491
-35% -$119K ﹤0.01% 1397
2022
Q1
$302K Sell
18,809
-4,423
-19% -$71K ﹤0.01% 1624
2021
Q4
$325K Buy
23,232
+928
+4% +$13K ﹤0.01% 1737
2021
Q3
$418K Sell
22,304
-6,089
-21% -$114K ﹤0.01% 1314
2021
Q2
$592K Buy
28,393
+2,510
+10% +$52.3K ﹤0.01% 1409
2021
Q1
$732K Buy
25,883
+3,503
+16% +$99.1K ﹤0.01% 1185
2020
Q4
$731K Buy
22,380
+6,806
+44% +$222K ﹤0.01% 1031
2020
Q3
$477K Sell
15,574
-348
-2% -$10.7K ﹤0.01% 963
2020
Q2
$260K Buy
+15,922
New +$260K ﹤0.01% 1304
2020
Q1
Sell
-14,451
Closed -$199K 1391
2019
Q4
$199K Sell
14,451
-1,696
-11% -$23.4K ﹤0.01% 1597
2019
Q3
$245K Buy
16,147
+2,005
+14% +$30.4K ﹤0.01% 1321
2019
Q2
$278K Sell
14,142
-1,854
-12% -$36.4K ﹤0.01% 1282
2019
Q1
$265K Buy
15,996
+123
+0.8% +$2.04K ﹤0.01% 1315
2018
Q4
$223K Sell
15,873
-3,076
-16% -$43.2K ﹤0.01% 1313
2018
Q3
$332K Buy
18,949
+1,661
+10% +$29.1K ﹤0.01% 1299
2018
Q2
$315K Buy
17,288
+568
+3% +$10.3K ﹤0.01% 1355
2018
Q1
$314K Sell
16,720
-2,550
-13% -$47.9K ﹤0.01% 1290
2017
Q4
$295K Buy
+19,270
New +$295K ﹤0.01% 1396